Aortic Stenosis Market to Grow at a Stellar Rate Owing to Rising Geriatric Population
The aortic stenosis market has seen tremendous growth in recent years. Aortic stenosis, also known as aortic valve stenosis, is a narrowing of the aortic valve opening that restricts blood flow from the heart into the main artery. It is one of the most common types of acquired valvular heart disease, affecting 2-7% of people over the age of 75. Devices used for treating aortic stenosis include balloon aortic valvuloplasty devices, transcatheter heart valves and surgical heart valves. Transcatheter aortic valve replacement (TAVR) procedures are gaining prominence over surgical aortic valve replacement due to benefits such as reduced risk of mortality and morbidity.
The global aortic stenosis market is estimated to be valued at US$ 10.18 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the aortic stenosis market are Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc., Braile Biom;dica, JenaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., and egnite, Inc.
The rising geriatric population globally is expected to present lucrative growth opportunities. As per the United Nations, the number of people aged 60 or above is expected to rise from 962 million globally in 2017 to 2.1 billion by 2050. This growing pool of elderly individuals is more prone to develop aortic stenosis.
Major players are focusing on emerging markets for future growth. The aortic stenosis market in Asia Pacific is expected to witness highest growth during the forecast period owing to improving healthcare infrastructure and rising medical tourism in the region.
Market drivers
The key market driver for the Aortic Stenosis Market Demand is the rising geriatric population globally. Older adults, especially those aged 75 and above, are more susceptible to aortic stenosis due to age-related degeneration of the aortic valve. According to the WHO, the number of people aged 65 years or older is projected to grow from an estimated 524 million in 2010 to nearly 1.5 billion in 2050 globally.
Get more insights on: - Aortic Stenosis Market
For Enhanced Understanding, Dive into the Report in the Language that Connects with You:-
- Industry
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Games
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
- News